Experimental cancer vaccine, combined with immunotherapy, continues to show benefits against melanoma, trial shows
By Katherine Dillinger, CNN (CNN) — An investigational mRNA vaccine used along with immunotherapy continues to show benefit for people with high-risk forms of the skin cancer melanoma, the drugmakers said Thursday. At a three-year follow-up with trial participants who had had a stage III or IV melanoma fully removed but were at high risk
Continue Reading